by Sue Robbins | Oct 31, 2014 | Headache Drugs
Sumatriptan delivered in an electric patch form applied to the skin was approved by the Federal Drug Administration (FDA) IN 2013 for the acute treatment of migraine. The iontophoretic sumatriptan patch is anticipated to become available in the U.S. in early or...
by Sue Robbins | Oct 20, 2014 | Headache Drugs
The current issue of HeadWise, (Volume 4, Issue 2) from the National Headache Foundation features an article written by Dr. Robbins regarding difficult to treat refractory headaches. Here is a portion of the article…. SPG (sphenopalatine ganglion) nerve blocks...
by Sue Robbins | Oct 9, 2014 | Headache Drugs
A new phase 2 trial of ALD403, a humanized monoclonal antibody directed against calcitonin gene-related peptide (CGRO) showed that the drug was safe and effective. Although preliminary, the results are promising, said lead author, David W. Dodick, professor,...
by Sue Robbins | Sep 25, 2014 | Headache Drugs
“Mast cell degranulation or parasympathetic hyperactivity, as encountered with asthma, might predispose an individual to the future onset of chronic migraine,” said Vincent Martin, MD, Professor of Medicine at the University of Cincinnati. The findings are...
by Sue Robbins | Sep 24, 2014 | Headache Drugs
According to research presented at the 56th Annual Scientific Meeting of the American Headache Society, most cases of new daily persistent headache (NDPH) are associated with a precipitating event such as a flu-like or viral illness. Robert P. Cowan, MD, Clinical...
